Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Nov 24;7(52):86766–86780. doi: 10.18632/oncotarget.13575

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © 2016 Peraldo et al.

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PMC Copyright notice

Panel A: representative images of WITT wound closure upon different conditions. NT: Not treated; OLIGO: treated with oligofectamine; siRNA CN: treated with negative control siRNA; siRNA LGALS1 and SYK: treated with specific siRNA for LGALS1 and SYK, respectively; siRNA combo: simultaneous treatment with siRNA for LGALS1 and SYK; TRAB: treatment with 5 nM of trabectedin. T0: time of wound. Panel B: Statistical analysis of percentage of wound closure; Bars representing the area of closure at different conditions; 100% corresponds to the area at the time of wounding.